LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

Kodu・Aktsiate loetelu・NeoGenomics Inc

NeoGenomics Inc

Suletud

7.87 -0.76

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

7.8

Max

7.95

Põhinäitajad
By Trading Economics
Sissetulek	-19M -45M
Müük	13M 181M
Kasumimarginaal	-24.867
Töötajad	2,200
EBITDA	-41M -48M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+30.26% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	4. nov 2025

Turustatistika
By TradingEconomics
Turukapital	303M 1.1B
Eelmine avamishind	8.63
Eelmine sulgemishind	7.87

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

7.7 / 10.27 Toetus ja vastupanu

NeoGenomics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. sept 2025, 17:01 UTC

Suurimad hinnamuutused turgudel

Eightco Holdings Stock Surges as Dan Ives Joins Board Amid Crypto Push

8. sept 2025, 17:01 UTC

Suurimad hinnamuutused turgudel

Tron Shares Rise After New Investment From Bravemorning

8. sept 2025, 15:14 UTC

Omandamised, ülevõtmised, äriostud

CoinShares to Go Public by Merging With SPAC

8. sept 2025, 13:58 UTC

Suurimad hinnamuutused turgudel

Forward Industries Shares Jump After Private Investment for Solana

5. sept 2025, 14:58 UTC

Suurimad hinnamuutused turgudel

Pineapple Financial Shares Rise After $100 Million Private Placement Closes

2. sept 2025, 16:52 UTC

Suurimad hinnamuutused turgudel

CleanCore Solutions Shares Drop After $175 Million Private Investment

8. sept 2025, 16:16 UTC

Tulu

Strategy Stock May Not Ever Make It Into the S&P 500 Index -- Barrons.com

8. sept 2025, 08:17 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. sept 2025, 08:17 UTC

Market Talk

Bitcoin Falls as Traders Eye U.S. Inflation Data -- Market Talk

5. sept 2025, 16:39 UTC

Omandamised, ülevõtmised, äriostud

Yorkville Acquisition: Commencing at Market Open on Sept 8, Common Stk Will Trade on Nasdaq Under New Ticker Symbol 'MCGA' >YORK

5. sept 2025, 16:39 UTC

Omandamised, ülevõtmised, äriostud

Yorkville Acquisition: Will Be Renamed to Trump Media Group CRO Strategy Upon Closing of Combination Between Yorkville, Trump Media & Technology Group Corp. and Crypto.com >YORK

5. sept 2025, 16:39 UTC

Omandamised, ülevõtmised, äriostud

Yorkville Acquisition Corp.: Announces Ticker Symbol Change to 'MCGA' Ahead of Trump Media Group CRO Strategy, Inc. Listing

5. sept 2025, 16:39 UTC

Omandamised, ülevõtmised, äriostud

Yorkville Acquisition: Outstanding Publicly Traded Units and Warrants Will Trade on Nasdaq Under New Ticker Symbols 'MCGAU' and 'MCGAW', Respectively >YORK

5. sept 2025, 14:43 UTC

Suurimad hinnamuutused turgudel

Pineapple Financial Shares Rise After $100M Private Placement Closes

5. sept 2025, 14:06 UTC

Omandamised, ülevõtmised, äriostud

Trump Media to Buy Cryptocurrency From Crypto.com In Deal Worth $104.7M

5. sept 2025, 07:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5. sept 2025, 07:50 UTC

Market Talk

Bitcoin Rises to One-Week High Before U.S. Jobs Data -- Market Talk

4. sept 2025, 08:03 UTC

Market Talk

Bitcoin Becoming More Affected by U.S. Data -- Market Talk

4. sept 2025, 07:45 UTC

Market Talk

Bitcoin Edges Lower as Traders Eye U.S. Jobs Data, Tariff Uncertainty -- Market Talk

3. sept 2025, 09:18 UTC

Market Talk

Bitcoin Falls as Bond Market Selloff Dents Sentiment -- Market Talk

2. sept 2025, 16:37 UTC

Suurimad hinnamuutused turgudel

CleanCore Solutions Shares Drop After $175M Private Investment

2. sept 2025, 13:25 UTC

Omandamised, ülevõtmised, äriostud

PharmaCyte Biotech Increased Stake in TNF by an Additional $3M >PMCB

2. sept 2025, 13:24 UTC

Omandamised, ülevõtmised, äriostud

PharmaCyte Biotech Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

2. sept 2025, 11:04 UTC

Omandamised, ülevõtmised, äriostud

Sharps Technology Acquires Over 2M SOL, the Native Asset of Solana

2. sept 2025, 07:31 UTC

Market Talk

Bitcoin Lifted by Fed Rate Cut Bets, Metaplanet Purchases -- Market Talk

1. sept 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

1. sept 2025, 07:07 UTC

Market Talk

Bitcoin Falls to 2-Month Low After Tech Slump -- Market Talk

29. aug 2025, 07:16 UTC

Market Talk

Bitcoin Falls as Traders Digest Waller Remarks, Await PCE Data -- Market Talk

29. aug 2025, 07:16 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28. aug 2025, 08:37 UTC

Market Talk

Bitcoin ETFs See Pickup in Demand -- Market Talk

Võrdlus sarnastega

Hinnamuutus

NeoGenomics Inc Prognoos

Hinnasiht

By TipRanks

30.26% tõus

12 kuu keskmine prognoos

Keskmine 10.33 USD 30.26%

Kõrge 14 USD

Madal 8 USD

Põhineb 11 Wall Streeti analüütiku instrumendi NeoGenomics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

11 ratings

Osta

Hoia

Müü

Põhineb 11 analüütiku instrumendi NeoGenomics Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

7.7 / 10.27Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.